Pharmaceutical

AlzeCure Publishes its Interim Report for January – September 2023

STOCKHOLM, SWEDEN / ACCESSWIRE / November 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced…

1 year ago

Stakeholders Endorse First-Ever Declaration on Self-Care for Universal Health Coverage

SAO PAULO / ACCESSWIRE / November 9, 2023 / The Global Self-Care Federation (GSCF) and the United for Self-Care Coalition…

1 year ago

Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies

ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIESANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to…

1 year ago

Former Amryt Pharma Leadership Team join Poolbeg

Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg PharmaPoolbeg team boosted by highly experienced executives with track…

1 year ago

Medexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 Million

Fiscal Q2 2024 revenue reflects a 9.4% increase over fiscal Q2 2023, demonstrating strong revenue growth and continued overall performanceManagement…

1 year ago

Moderna to Present at Upcoming Conferences in November 2023

CAMBRIDGE, MA / ACCESSWIRE / November 8, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming…

1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023

Reports Net Revenues of $180.6 Million for the Three Months Ended September 30, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / November…

1 year ago

Apprentice.io Announces New Product Release to Drive Digital Pharmaceutical Manufacturing Initiatives in 2024

JERSEY CITY, NJ / ACCESSWIRE / November 8, 2023 / Apprentice, which helps life science manufacturers get treatments to patients…

1 year ago

Model N Launches Channel Collaboration to Strengthen Visibility for High-Tech Manufacturers and Their Channel Partners

Channel Collaboration offers real-time channel data visibility and equips high-tech manufacturers with critical decision-making and global complianceSAN MATEO, Calif.--(BUSINESS WIRE)--Model…

1 year ago

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule

SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced…

1 year ago